SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on June 11, 2024, reporting events occurring on June 10, 2024. The Company is incorporated in Delaware and its common stock trades under the symbol "BSGM" on The NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding listing standards.
Material Changes
- Delisting Notice: The Company received formal notice from the Nasdaq Hearings Panel to delist its common stock due to continued non-compliance with the minimum stockholders' equity requirement (Nasdaq Listing Rule 5550(b)(2)).
- Trading Suspension: Trading on Nasdaq is suspended effective the open of business on Wednesday, June 12, 2024.
- Market Transfer: The stock is expected to trade on the OTC Markets' Pink Current Information tier under the symbol "BSGM" effective June 12, 2024.
Outlook, Risks, and Management Commentary
Management plans to seek reconsideration of the delisting decision from the Panel and intends to appeal to the Nasdaq Listing and Hearing Review Council. The Company explicitly states there can be no assurance of success in obtaining reconsideration or satisfying conditions required to maintain a Nasdaq listing.
Investor Verification Checklist
- Verify the Company's current stockholders' equity balance to understand the specific deficit causing non-compliance.
- Monitor the status of the appeal to the Nasdaq Listing and Hearing Review Council.
- Confirm the transition of trading to the OTC Markets Pink tier and associated liquidity implications.
- Review subsequent filings for any updates on the delisting appeal or potential reverse stock splits to regain compliance.